WO2003063902A3 - Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers - Google Patents

Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers Download PDF

Info

Publication number
WO2003063902A3
WO2003063902A3 PCT/US2003/003358 US0303358W WO03063902A3 WO 2003063902 A3 WO2003063902 A3 WO 2003063902A3 US 0303358 W US0303358 W US 0303358W WO 03063902 A3 WO03063902 A3 WO 03063902A3
Authority
WO
WIPO (PCT)
Prior art keywords
inactivation
west nile
nile virus
alloxazine
derivating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/003358
Other languages
French (fr)
Other versions
WO2003063902A2 (en
Inventor
Heather Reddy
Raymond P Goodrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo BCT Inc
Original Assignee
Gambro Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Inc filed Critical Gambro Inc
Priority to DE60325693T priority Critical patent/DE60325693D1/en
Priority to JP2003563591A priority patent/JP4634039B2/en
Priority to CA2474448A priority patent/CA2474448C/en
Priority to AU2003208986A priority patent/AU2003208986A1/en
Priority to EP03707711A priority patent/EP1471940B1/en
Publication of WO2003063902A2 publication Critical patent/WO2003063902A2/en
Publication of WO2003063902A3 publication Critical patent/WO2003063902A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Methods and apparatuses are provided for inactivation of parasites (Pl. falciparum) or virus (West Nile Virus) in fluids. Preferably the fluids contain blood or blood products and comprise biologically active proteins. Preferred methods include the steps of adding an effective, non-toxic amount of a photosensitizer (riboflavin) to a fluid and exposing the fluid to photoradiation sufficient to activate the photosensitizer whereby microorganisms are inactivated.
PCT/US2003/003358 2002-02-01 2003-02-03 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers Ceased WO2003063902A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE60325693T DE60325693D1 (en) 2002-02-01 2003-02-03 INACTIVATION OF WEST NILE VIRUS AND PLASMODIUM FALCIPARUM BY THE USE OF ALLOXAZINE DERIVATIVES OF PHOTOSENSITIZERS
JP2003563591A JP4634039B2 (en) 2002-02-01 2003-02-03 Inactivation of West Nile virus and malaria using photosensitizers
CA2474448A CA2474448C (en) 2002-02-01 2003-02-03 Inactivation of west nile virus and malaria using photosensitizers
AU2003208986A AU2003208986A1 (en) 2002-02-01 2003-02-03 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers
EP03707711A EP1471940B1 (en) 2002-02-01 2003-02-03 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitisers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35316202P 2002-02-01 2002-02-01
US60/353,162 2002-02-01

Publications (2)

Publication Number Publication Date
WO2003063902A2 WO2003063902A2 (en) 2003-08-07
WO2003063902A3 true WO2003063902A3 (en) 2003-09-04

Family

ID=27663184

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/003358 Ceased WO2003063902A2 (en) 2002-02-01 2003-02-03 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers

Country Status (6)

Country Link
EP (1) EP1471940B1 (en)
JP (1) JP4634039B2 (en)
AU (1) AU2003208986A1 (en)
CA (1) CA2474448C (en)
DE (1) DE60325693D1 (en)
WO (1) WO2003063902A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101868255A (en) * 2007-08-01 2010-10-20 科安比司特生物技术有限责任公司 Pathogen inactivation of whole blood

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1469891B1 (en) * 2002-02-01 2009-04-15 CaridianBCT Biotechnologies, LLC Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
GB0323699D0 (en) * 2003-10-09 2003-11-12 Univ London Use of photosensitisation
GB0515550D0 (en) 2005-07-29 2005-09-07 Univ Strathclyde Inactivation of staphylococcus species
GB0721374D0 (en) 2007-10-31 2007-12-12 Univ Strathclyde Optical device for the environmental control of pathogenic bacteria
US9333274B2 (en) 2014-07-31 2016-05-10 Vital Vio, Inc. Disinfecting light fixture
US9439989B2 (en) 2014-07-31 2016-09-13 Vital Vio, Inc. Disinfecting light fixture
WO2016209631A1 (en) 2015-06-26 2016-12-29 Kenall Manufacturing Company Single-emitter lighting device that outputs a minimum amount of power to produce integrated radiance values sufficient for deactivating pathogens
US10434202B2 (en) 2015-06-26 2019-10-08 Kenall Manufacturing Company Lighting device that deactivates dangerous pathogens while providing visually appealing light
US11273324B2 (en) 2015-07-14 2022-03-15 Illumipure Corp LED structure and luminaire for continuous disinfection
US10918747B2 (en) 2015-07-30 2021-02-16 Vital Vio, Inc. Disinfecting lighting device
US10357582B1 (en) 2015-07-30 2019-07-23 Vital Vio, Inc. Disinfecting lighting device
US9927097B2 (en) 2015-07-30 2018-03-27 Vital Vio Inc. Single diode disinfection
US10006619B1 (en) 2016-12-28 2018-06-26 WLC Enterprises, Inc. Combination LED lighting and fan apparatus
US20180185533A1 (en) 2016-12-29 2018-07-05 Vital Vio, Inc. Control systems for disinfecting light systems and methods of regulating operations of disinfecting light systems
US10835627B2 (en) 2017-12-01 2020-11-17 Vital Vio, Inc. Devices using flexible light emitting layer for creating disinfecting illuminated surface, and related method
US10309614B1 (en) 2017-12-05 2019-06-04 Vital Vivo, Inc. Light directing element
US10413626B1 (en) 2018-03-29 2019-09-17 Vital Vio, Inc. Multiple light emitter for inactivating microorganisms
US12194168B2 (en) 2018-12-19 2025-01-14 Vyv, Inc. Lighting and dissipation device
US11639897B2 (en) 2019-03-29 2023-05-02 Vyv, Inc. Contamination load sensing device
US11541135B2 (en) 2019-06-28 2023-01-03 Vyv, Inc. Multiple band visible light disinfection
US11369704B2 (en) 2019-08-15 2022-06-28 Vyv, Inc. Devices configured to disinfect interiors
US11878084B2 (en) 2019-09-20 2024-01-23 Vyv, Inc. Disinfecting light emitting subcomponent
US11499707B2 (en) 2020-04-13 2022-11-15 Calyxpure, Inc. Light fixture having a fan and ultraviolet sterilization functionality
US11759540B2 (en) 2021-05-11 2023-09-19 Calyxpure, Inc. Portable disinfection unit
US20220362432A1 (en) 2021-05-11 2022-11-17 Calyxpure, Inc. Sensor System for a Light Fixture Having Ultraviolet Sterilization Functionality

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028120A1 (en) * 1991-05-10 1994-12-08 New York Blood Center, Inc. Process for the sterilization of biological compositions and the product produced thereby
WO2000004930A2 (en) * 1998-07-21 2000-02-03 Gambro, Inc. Method for inactivation of microorganisms using photosensitizers
WO2001028599A1 (en) * 1999-10-19 2001-04-26 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
WO2001078792A1 (en) * 2000-04-12 2001-10-25 The American National Red Cross Method of inactivating pathogens
WO2001096340A1 (en) * 2000-06-15 2001-12-20 Gambro, Inc. Method for inactivation of microorganisms using photosensitizers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2712493B1 (en) * 1993-11-16 1996-01-19 Centre Nat Rech Scient Use of photosensitizers derived from the phorbine nucleus for the decontamination of blood infected by parasites and / or viruses.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028120A1 (en) * 1991-05-10 1994-12-08 New York Blood Center, Inc. Process for the sterilization of biological compositions and the product produced thereby
WO2000004930A2 (en) * 1998-07-21 2000-02-03 Gambro, Inc. Method for inactivation of microorganisms using photosensitizers
WO2001028599A1 (en) * 1999-10-19 2001-04-26 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
WO2001078792A1 (en) * 2000-04-12 2001-10-25 The American National Red Cross Method of inactivating pathogens
WO2001096340A1 (en) * 2000-06-15 2001-12-20 Gambro, Inc. Method for inactivation of microorganisms using photosensitizers

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
APPLEYARD: "Photosensitivity of Semliki forest and other viruses", JOURNAL OF GENERAL VIROLOGY, vol. 1, - 1967, pages 143 - 152, XP008018664 *
FRANCKI ET AL.: "Classification and nomenclature of viruses, Fifth report of the international committee on taxonomy of viruses, Archives of virology Supplementum 2", SPRINGER-VERLAG, WIEN NEW-YORK, XP002242777 *
SOLIMAN ET AL.: "Application of an immunoperoxidase monolyer assay for the detection of arboviral antibodies", JOURNAL OF VIROLOGICAL METHODS, vol. 65, no. 2, 1997, pages 147 - 151, XP002242775 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101868255A (en) * 2007-08-01 2010-10-20 科安比司特生物技术有限责任公司 Pathogen inactivation of whole blood

Also Published As

Publication number Publication date
AU2003208986A1 (en) 2003-09-02
EP1471940B1 (en) 2009-01-07
CA2474448A1 (en) 2003-08-07
CA2474448C (en) 2010-09-07
WO2003063902A2 (en) 2003-08-07
EP1471940A2 (en) 2004-11-03
DE60325693D1 (en) 2009-02-26
JP2005519920A (en) 2005-07-07
JP4634039B2 (en) 2011-02-16

Similar Documents

Publication Publication Date Title
WO2003063902A3 (en) Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers
CA2381594A1 (en) Method for inactivation of microorganisms using photosensitizers
AU7580700A (en) Isoalloxazine derivatives to neutralize biological contaminants
WO2000004930A3 (en) Method for inactivation of microorganisms using photosensitizers
DK1455595T3 (en) Microorganism for the biological detoxification of mycotoxins, especially ochratoxins and / or zearalenones, and their method and use
EP1972351A3 (en) Method for inactivation of microorganisms using photosensitizers
DK1372650T3 (en) Combinations containing an antidiarrheal agent and an epothilone or epothilone derivative
ATE539701T1 (en) COMPOSITE SLING FOR THE TREATMENT OF INCONTINENCE
WO2005089100A3 (en) Decontamination formulations for disinfection and sterilization
ATE464863T1 (en) IMPLANTABLE MEDICAL DEVICE FOR SELECTIVE MODULATION OF THE DELIVERY OF AGENTS IN SITU
WO2002096471A3 (en) Viral inactivation process using antioxidant
WO2005034855A3 (en) Photodynamic inactivation of bacterial spores
AU2001233009A1 (en) Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation
EP1421185A4 (en) RAPID STERILIZATION AND PREPARATION OF VACCINE
DK1779877T3 (en) Carrying material for medical implants
AU2002367979A8 (en) Devices, systems and methods for reducing levels of pro-inflammartory or anti-inflammatrory stimulators or mediators in blood products
BR0213994A (en) Heterocyclic Glycinamide Derivatives and Their Medical Uses
WO2005048944A3 (en) Activatable photodynamic therapy agents
DE60311254D1 (en) FLUOR CONTAINING WATER-SOLUBLE NON-TENSANTS, USE THEREOF AND METHOD OF PREPARING THEM
AU2003270470A1 (en) Vitreoretinal tamponades based on fluorosilicone fluids
BR0112514A (en) Uses for nad synthetase inhibitors
WO2005018687A3 (en) Particle-size reduction apparatus, and use thereof
MD1979F1 (en) Method of secondary cataract treatment
WO2001089558A3 (en) Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
WO2005004862A3 (en) Method for photodynamic inactivation of pathogens using ala

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2474448

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003563591

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003707711

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003707711

Country of ref document: EP